More top hospitals aren’t offering Biogen Alzheimer’s drug

Hello, everybody, and the way are you as we speak? Cloudy skies are hovering this morning over the Pharmalot campus, the place the official mascot awaits a play date and the brief particular person is, as soon as once more, sleeping in. As for us, we’re engaged within the common routines of readying our to-do listing and brewing cups of stimulation. Our selection as we speak, for these monitoring such issues, is southern pecan, all the best way from New Orleans. Be happy to hitch us. Keep in mind, no prescription is required, so no want to trace rebates. In the meantime, listed below are some tidbits. Hope you’ve a smashing day and, as all the time, do keep up a correspondence. We respect your suggestions and recommendations. …

The group that negotiates provide contracts on behalf of greater than 95% of the nation’s tutorial hospitals estimates its members are ordering only one to 5 vials of the controversial Biogen (BIIB) Alzheimer’s drugs every day, STAT reviews. And one other 15 university-affiliated hospitals should not providing the drug, together with Johns Hopkins, the College of California, Los Angeles, and the College of Michigan. The disinterest within the drug is one more blow to an already-catastrophic industrial rollout for the drugs, which the corporate had hoped could be a blockbuster product for the estimated 5.8 million People with Alzheimer’s.